New Brunswick, NJ (January 27th, 2022) - Johnson & Johnson (NYSE: JNJ) will participate in Citi's 2022 Virtual Healthcare Conference on Wednesday, February 23rd, Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time).

This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately 48 hours after the live webcast.

  • Media Contacts
    Stephanie Hartgrove
    (732) 524-1941

    Investor Contacts
    Sarah Wood
    (732) 524-2617

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Johnson & Johnson published this content on 27 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 January 2022 22:35:09 UTC.